Search
Proglumetacin
go.drugbank.com/drugs/DB13527InvestigationalCategories: Non COX-2 selective NSAIDS, Heterocyclic Compounds, 2-RingChlormadinone
go.drugbank.com/drugs/DB13528InvestigationalMixtures: LADEE®, ADELLA®Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesMepindolol
go.drugbank.com/drugs/DB13530InvestigationalMepindolol is a 2-methyl derivative of pindolol. It is a beta blocker.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 SubstratesXomaZyme-791
go.drugbank.com/drugs/DB17216ExperimentalCategories: N-Glycosyl Hydrolases, Ribosome Inactivating Proteins, Type 2Redaporfin
go.drugbank.com/drugs/DB17219InvestigationalSynonyms: 3,3',3'',3'''-(7,8,17,18-tetrahydroporphyrin-5,10,15,20-tetrayl)tetrakis(2,4-difluoro-n-methylbenzenesulfonamide), Benzenesulfonamide, 3,3',3'',3'''-(7,8,17,18-tetrahydro-21h,23h-porphine-5,10,15,20-tetrayl)tetrakis(2,4-difluoro-n-methyl-Categories: P-glycoprotein substrates, Heterocyclic Compounds, 1-RingBCL-005
go.drugbank.com/drugs/DB17242ExperimentalBCL-005 is a product formed by fused (hybrid) melanoma-dendritic cells.
GI-101
go.drugbank.com/drugs/DB17243InvestigationalGI-101 is a bi-specific fragment crystallizable region (Fc) fusion protein containing a cluster of differentiation 80 ectodomain as an N-terminal moiety and interleukin-2 variant as a C-terminal moiety
ISB 1342
go.drugbank.com/drugs/DB17251InvestigationalISB 1342 is a bispecific antibody simultaneously targeting CD38 and CD3.
Tarlatamab
go.drugbank.com/drugs/DB17256ApprovedInvestigationalTarlatamab is a first-in-class T-cell engager used to treat extensive-stage small cell lung cancer. … [L50748] It is a bispecific monoclonal antibody that targets CD3 expressed on the surface of T-cells and delta-like ligand 3 (DLL3), an inhibitory ligand that suppresses Notch signaling and is highly expressed
Synonyms: Immunoglobulin scfv-scfv-scfc, anti-(homo sapiens dll3 (delta-like ligand 3)) and anti-(homo sapiens cd3e (cd3 epsilon, leu-4)), monoclonal antibody single chain (scfv)2-scfc, bispecificEtentamig
go.drugbank.com/drugs/DB17268InvestigationalTNB-383B is a CD3 and B-cell maturation antigen T-cell engaging bispecific antibody.
Synonyms: Anti-BCMA x aCD3 T-BsAb TNB-383B, Anti-BCMA/Anti-CD3 T-cell Engaging Bispecific Antibody ABBV-383